ArticleThe Journal of antimicrobial chemotherapy2024

Investigating the treatment shortening potential of a combination of bedaquiline, delamanid and moxifloxacin with and without sutezolid, in a murine tuberculosis model with confirmed drug exposures.

Kerstin Walter et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.